197 related articles for article (PubMed ID: 22337776)
1. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry.
McMillin GA; Davis R; Carlisle H; Clark C; Marin SJ; Moody DE
J Anal Toxicol; 2012 Mar; 36(2):81-7. PubMed ID: 22337776
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
Marin SJ; McMillin GA
Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
[TBL] [Abstract][Full Text] [Related]
3. Investigation of buprenorphine-related deaths using urinary metabolite concentrations.
Mariottini C; Kriikku P; Ojanperä I
Drug Test Anal; 2022 Oct; 14(10):1696-1702. PubMed ID: 35834288
[TBL] [Abstract][Full Text] [Related]
4. Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.
Mariottini C; Gergov M; Ojanperä I
Drug Test Anal; 2021 Sep; 13(9):1658-1667. PubMed ID: 34047070
[TBL] [Abstract][Full Text] [Related]
5. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
Regina KJ; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():23-31. PubMed ID: 24095872
[TBL] [Abstract][Full Text] [Related]
7. LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users.
Seldén T; Roman M; Druid H; Kronstrand R
Forensic Sci Int; 2011 Jun; 209(1-3):113-9. PubMed ID: 21306845
[TBL] [Abstract][Full Text] [Related]
8. Urine naloxone concentration at different phases of buprenorphine maintenance treatment.
Heikman P; Häkkinen M; Gergov M; Ojanperä I
Drug Test Anal; 2014 Mar; 6(3):220-5. PubMed ID: 23512803
[TBL] [Abstract][Full Text] [Related]
9. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Huang W; Moody DE; McCance-Katz EF
Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
[TBL] [Abstract][Full Text] [Related]
10. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
Kronstrand R; Seldén TG; Josefsson M
J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
[TBL] [Abstract][Full Text] [Related]
11. [Determination of buprenorphine in urine].
Hegstad S; Christophersen AS; Khiabani HZ
Tidsskr Nor Laegeforen; 2008 Jan; 128(2):184-5. PubMed ID: 18202730
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry.
Joshi A; Parris B; Liu Y; Heidbreder C; Gerk PM; Halquist M
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390058
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.
Kacinko SL; Concheiro-Guisan M; Shakleya DM; Huestis MA
Anal Bioanal Chem; 2008 Nov; 392(5):903-11. PubMed ID: 18758763
[TBL] [Abstract][Full Text] [Related]
14. Rapid, hydrolysis-free, dilute-and-shoot method for the determination of buprenorphine, norbuprenorphine and their glucuronides in urine samples using UHPLC-MS/MS.
Agostini M; Renzoni C; Pierini E; Piergiovanni M; Termopoli V; Famiglini G; Palma P; Cappiello A
J Pharm Biomed Anal; 2019 Mar; 166():236-243. PubMed ID: 30660808
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry.
Liu Y; Li X; Xu A; Nasser AF; Heidbreder C
J Pharm Biomed Anal; 2016 Feb; 120():142-52. PubMed ID: 26730511
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry.
Swortwood MJ; Scheidweiler KB; Barnes AJ; Jansson LM; Huestis MA
J Chromatogr A; 2016 May; 1446():70-7. PubMed ID: 27083254
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of buprenorphine and norbuprenorphine in urine using liquid chromatography tandem mass spectrometry.
Fox EJ; Tetlow VA; Allen KR
J Anal Toxicol; 2006 May; 30(4):238-44. PubMed ID: 16803661
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma.
Pirnay S; Hervé F; Bouchonnet S; Perrin B; Baud FJ; Ricordel I
J Pharm Biomed Anal; 2006 Jun; 41(4):1135-45. PubMed ID: 16554136
[TBL] [Abstract][Full Text] [Related]
19. Urinary Buprenorphine, Norbuprenorphine and Naloxone Concentrations and Ratios: Review and Potential Clinical Implications.
Warrington JS; Warrington GS; Francis-Fath S; Brooklyn J
J Addict Med; 2020 Dec; 14(6):e344-e349. PubMed ID: 32530884
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes.
Oechsler S; Skopp G
Forensic Sci Int; 2010 Feb; 195(1-3):73-7. PubMed ID: 20006453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
